Technical Analysis for RHHBY - Roche Hldg Ltd Spons
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Up | Up | Up |
| Historical RHHBY trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| Slingshot Bullish | Bullish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | -0.45% | |
| MACD Bullish Signal Line Cross | Bullish | -0.45% | |
| New 52 Week Closing High | Bullish | -0.45% | |
| Narrow Range Bar | Range Contraction | -0.45% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Life Sciences Pharmaceutical Industry In China Pharmaceutical Products Infectious Diseases Disease Neuroscience Gene Expression Genentech Hoffmann La Roche Diabetes Care Chugai Pharmaceutical Co. Roche
Life Sciences Pharmaceutical Industry In China Pharmaceutical Products Infectious Diseases Disease Neuroscience Gene Expression Genentech Hoffmann La Roche Diabetes Care Chugai Pharmaceutical Co. Roche
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 42.88 |
| 52 Week Low | 25.1 |
| Average Volume | 1,178,930 |
| 200-Day Moving Average | 35.7176 |
| 50-Day Moving Average | 39.2184 |
| 20-Day Moving Average | 40.4205 |
| 10-Day Moving Average | 40.1580 |
| Average True Range | 2.0691 |
| ADX | 54.47 |
| +DI | 6.0863 |
| -DI | 44.8577 |
| Chandelier Exit (Long, 3 ATRs ) | 36.6727 |
| Chandelier Exit (Short, 3 ATRs ) | 38.2292 |
| Upper Bollinger Band | 45.1011 |
| Lower Bollinger Band | 35.7399 |
| Percent B (%b) | 0.71 |
| BandWidth | 23.1595 |
| MACD Line | 0.5961 |
| MACD Signal Line | 0.4159 |
| MACD Histogram | 0.1802 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 42.7650 | ||||
| Resistance 3 (R3) | 42.7367 | 42.5833 | 42.7025 | ||
| Resistance 2 (R2) | 42.5833 | 42.4878 | 42.5975 | 42.6817 | |
| Resistance 1 (R1) | 42.4867 | 42.4288 | 42.5350 | 42.5150 | 42.6608 |
| Pivot Point | 42.3333 | 42.3333 | 42.3575 | 42.3475 | 42.3333 |
| Support 1 (S1) | 42.2367 | 42.2378 | 42.2850 | 42.2650 | 42.1192 |
| Support 2 (S2) | 42.0833 | 42.1788 | 42.0975 | 42.0984 | |
| Support 3 (S3) | 41.9867 | 42.0833 | 42.0775 | ||
| Support 4 (S4) | 42.0150 |
